BOSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leading AI-powered precision neurotechnology company, today announced that it has acquired Snap Diagnostics, a premier home sleep testing (HST) provider serving patients in all 50 states. The acquisition more than doubles Beacon’s patient reach, making it one of the largest HST providers in the United States and establishing a national channel to bring EEG-enabled home sleep testing to more patients starting in 2027..

波士顿，2026年10月22日（环球电讯社）——领先的人工智能驱动精准神经技术公司Beacon Biosignals今日宣布，已收购全美50个州均提供服务的 premier 家庭睡眠检测（HST）提供商Snap Diagnostics。此次收购使Beacon的患者覆盖范围扩大一倍以上，使其成为美国最大的家庭睡眠检测提供商之一，并建立起一个全国性渠道，自2027年起为更多患者提供基于脑电图（EEG）的家庭睡眠检测服务。

Consumer wearables and cardiopulmonary devices estimate sleep indirectly from signals like movement, heart rate, and airflow. Beacon’s FDA 510(k)-cleared Waveband headband measures the brain’s electrical activity (EEG) directly, capturing the sleep fragmentation behind many of the daytime symptoms and long-term risks of obstructive sleep apnea (OSA).

消费级可穿戴设备和心肺设备通过运动、心率和气流等信号间接估算睡眠。Beacon 的 Waveband 头带已获得美国食品药品监督管理局（FDA）510(k) 许可，可直接测量大脑电活动（脑电图），从而捕捉导致阻塞性睡眠呼吸暂停（OSA）诸多日间症状和长期风险的睡眠碎片化现象。

Combined with AI-driven analysis from the Beacon Platform, EEG-enabled home testing gives clinicians a more complete picture of OSA and disturbed nighttime sleep without an overnight lab visit..

结合Beacon平台的人工智能驱动分析，支持脑电图（EEG）的居家检测让临床医生能够在无需过夜实验室就诊的情况下，更全面地了解阻塞性睡眠呼吸暂停（OSA）和夜间睡眠紊乱的情况。

“Sleep happens in the brain, so measuring brain activity is essential to fully understanding sleep and its impact on health,” said Jacob Donoghue, MD, PhD, CEO and co-founder of Beacon Biosignals. “Snap gives us the national reach to bring EEG-enabled testing to nearly every clinician who sees patients at risk for sleep disorders.

“睡眠发生在大脑中，因此测量大脑活动对于全面理解睡眠及其对健康的影响至关重要，”Beacon Biosignals 的首席执行官兼联合创始人 Jacob Donoghue 医学博士、哲学博士表示。“Snap 为我们提供了覆盖全国的能力，使基于脑电图（EEG）的检测能够惠及几乎每一位接诊睡眠障碍风险患者的临床医生。”

We believe sleep diagnostics will soon extend well beyond sleep apnea, with the potential for at-home neurophysiology to help identify early signs of neurodegenerative disease and support more personalized psychiatric care. This acquisition is a major step toward that future.”.

我们相信，睡眠诊断将很快超越睡眠呼吸暂停的范畴，居家神经生理检测有望帮助识别神经退行性疾病的早期迹象，并支持更加个性化的精神科护理。此次收购是迈向这一未来的重要一步。

Snap’s end-to-end service lets primary care physicians, advanced practice providers, telehealth providers, and specialists such as psychiatrists, cardiologists, endocrinologists, and weight management physicians order a home sleep test without in-house sleep expertise. Snap ships the test directly to the patient, with results scored and interpreted by qualified sleep professionals in accordance with American Academy of Sleep Medicine (AASM) guidance.

Snap 的端到端服务让初级保健医生、高级执业提供者、远程医疗提供者以及精神科医生、心脏科医生、内分泌科医生和体重管理医生等专科医生，无需具备内部睡眠专业知识即可订购居家睡眠测试。Snap 将测试设备直接寄送给患者，并由合格的睡眠专业人员根据美国睡眠医学会（AASM）的指导方针对结果进行评分和解读。

As an Independent Diagnostic Testing Facility (IDTF), Snap also bills Medicare and commercial insurers directly, allowing clinicians to offer home sleep testing without managing equipment, logistics, or billing..

作为独立诊断检测设施（IDTF），Snap 还直接向医疗保险和商业保险公司开具账单，使临床医生能够提供居家睡眠检测服务，而无需管理设备、物流或账单事务。

“Nearly one in three Americans experience sleep symptoms, yet there are only about 6,000 board-certified sleep physicians in the country,” said Donoghue. “By making sleep testing more accessible through primary care and other specialties, we can help identify more patients who need evaluation and connect them with the right care.

“近三分之一的美国人存在睡眠问题症状，但全国仅有约6,000名获得董事会认证的睡眠医学医师，”多诺霍表示。“通过初级保健及其他专科提高睡眠检测的可及性，我们可以帮助识别更多需要评估的患者，并使他们获得合适的诊疗服务。”

We see sleep specialists as essential partners in this effort, helping more patients benefit from their expertise and ensuring those with complex needs receive the specialized care they deserve.”.

我们将睡眠专家视为这一努力中不可或缺的合作伙伴，帮助更多患者受益于他们的专业知识，并确保有复杂需求的患者获得他们应得的专业照护。

Beacon’s acquisition of Snap expands its reach in OSA diagnostics while creating a pathway to bring its neurophysiology and AI capabilities into broader clinical care. Beacon’s technology supports clinical trials across neurological, psychiatric, and sleep disorders with more than half of the world’s top 10 biopharmaceutical companies, including Johnson & Johnson, Bristol Myers Squibb, UCB, Harmony, and Takeda.

Beacon 收购 Snap，扩大了其在阻塞性睡眠呼吸暂停（OSA）诊断领域的影响力，同时为其将神经生理学和人工智能能力引入更广泛的临床护理铺平了道路。Beacon 的技术支持神经系统、精神系统和睡眠障碍领域的临床试验，全球十大生物制药公司中有一半以上与其合作，包括强生、百时美施贵宝、优时比、Harmony 和武田制药。

These partners rely on clinically validated EEG and AI-derived biomarkers from the Beacon Platform, powered by a foundation model of brain activity trained on millions of hours of EEG, to evaluate the next generation of brain health therapies..

这些合作伙伴依托 Beacon 平台提供的临床验证脑电图（EEG）和人工智能衍生生物标志物，评估下一代脑部健康疗法。该平台由一个在数百万小时脑电图数据上训练而成的脑活动基础模型驱动。

By bringing this platform into clinical care, Beacon aims to bridge drug development and patient care, applying the same underlying technology used to develop new treatments to help clinicians better diagnose and manage the patients those treatments are designed to help.

通过将这一平台引入临床护理，Beacon 旨在弥合药物开发与患者护理之间的鸿沟，将用于开发新疗法的底层技术应用于帮助临床医生更准确地诊断和管理这些疗法所针对的患者。

Frequently Asked Questions

常见问题

Q: What is EEG-enabled home sleep testing, and when will it be available?

问：什么是支持脑电图（EEG）的居家睡眠检测？何时可以投入使用？

A: EEG-enabled home sleep testing adds direct measurement of brain activity to the cardiopulmonary signals a standard home sleep test captures, such as airflow, respiratory effort, and oxygen saturation. Beacon plans to bring EEG-enabled home sleep testing to more patients starting in 2027.

A：支持脑电图（EEG）的居家睡眠监测在标准居家睡眠监测所捕获的心肺信号（如气流、呼吸努力和血氧饱和度）基础上，增加了对大脑活动的直接测量。Beacon 计划从2027年开始，将支持脑电图的居家睡眠监测推广至更多患者。

Q: What does Beacon’s acquisition of Snap Diagnostics mean for patients?

问：Beacon 收购 Snap Diagnostics 对患者意味着什么？

A: More patients can access clinical-grade home sleep testing. Snap’s end-to-end service is available in all 50 states, expanding Beacon’s reach to healthcare providers outside the sleep specialty, where patients with undiagnosed sleep disorders often first seek care.

A: 更多患者可以获得临床级家庭睡眠检测服务。Snap 的端到端服务已覆盖美国全部 50 个州，将 Beacon 的服务范围扩展至睡眠专科以外的医疗保健提供者，而未确诊睡眠障碍的患者往往首先在这些机构寻求诊疗。

Q: Will anything change for current Snap customers?

问：现有 Snap 客户是否会受到任何影响？

A: No. For the foreseeable future, Snap will remain a subsidiary of Beacon Biosignals, with no change to its name or services.

A：不。在可预见的未来，Snap 将继续作为 Beacon Biosignals 的子公司运营，其名称和服务均保持不变。

Q: Who can order a home sleep test through Snap Diagnostics?

问：谁可以通过 Snap Diagnostics 订购居家睡眠测试？

A: In addition to sleep specialists, sleep centers, and academic medical centers, Beacon can now serve healthcare providers outside the sleep specialty, including primary care physicians, advanced practice providers, telehealth providers, and other medical specialists.

A：除了睡眠专科医生、睡眠中心和学术医疗中心外，Beacon 现在还可以为睡眠专科以外的医疗保健提供者提供服务，包括初级保健医生、高级执业提供者、远程医疗提供者以及其他医学专家。

Q: Who interprets the sleep study results?

问：谁解读睡眠监测结果？

A: Snap’s sleep technicians score every Snap study, and trained specialists interpret it, consistent with AASM guidance that home sleep apnea test data be interpreted by, or under the oversight of, a board-certified sleep medicine physician. Ordering clinicians receive a completed interpretation without needing in-house sleep expertise..

A：Snap 的睡眠技师对每一项 Snap 研究进行评分，并由经过培训的专业人员进行解读，这符合美国睡眠医学会（AASM）的指导方针，即家庭睡眠呼吸暂停测试数据应由获得董事会认证的睡眠医学医师解读或在其监督下解读。开具检查单的临床医生无需具备内部的睡眠专业知识，即可收到完整的解读报告。

Q: Which patients are appropriate for home sleep testing?

问：哪些患者适合进行家庭睡眠监测？

A: Under AASM guidance, home sleep apnea testing is appropriate for uncomplicated adult patients whose signs and symptoms indicate an increased risk of moderate-to-severe OSA, such as excessive daytime sleepiness combined with loud snoring or witnessed breathing pauses.

A：根据美国睡眠医学会（AASM）的指导，对于症状和体征提示中度至重度阻塞性睡眠呼吸暂停（OSA）风险增加的无并发症成年患者（例如，白天过度嗜睡伴响亮打鼾或被目击的呼吸暂停），居家睡眠呼吸暂停检测是适宜的。

Q: How is a Snap Diagnostics home sleep test billed?

问：Snap Diagnostics 家庭睡眠测试如何计费？

A: Snap is a Medicare-registered IDTF accredited by The Joint Commission, and it bills Medicare and commercial insurers directly. Clinicians place the order, and Snap takes care of the rest, from shipping the test to the patient through scoring, interpretation, and billing.

A：Snap 是一家在 Medicare（美国联邦医疗保险）注册的独立诊断测试机构（IDTF），并获得联合委员会认证。它直接向 Medicare 和商业保险公司开具账单。临床医生下达检测订单，Snap 负责处理后续所有事宜，包括向患者寄送检测套件、评分、解读结果以及开具账单。

About Beacon Biosignals

关于 Beacon Biosignals

Beacon Biosignals is transforming precision medicine for the brain. Our FDA-cleared, at-home EEG and cardiopulmonary devices deliver clinical-grade sleep diagnostics in patients’ natural environments. The Beacon Platform applies AI/ML to stratify patients and generate digital endpoints for interventional clinical trials.

Beacon Biosignals 正在变革脑部精准医疗。我们获得美国食品药品监督管理局（FDA）许可的居家脑电图（EEG）和心肺设备，能够在患者的自然环境中提供临床级睡眠诊断。Beacon 平台应用人工智能/机器学习技术对患者进行分层，并为干预性临床试验生成数字终点。

It also helps characterize and track the progression of neurodegenerative, neuropsychiatric, and primary sleep disorders. Learn more at www.beacon.bio..

它还有助于表征和追踪神经退行性疾病、神经精神疾病以及原发性睡眠障碍的进展。更多信息请访问 www.beacon.bio。

About Snap Diagnostics

关于 Snap Diagnostics

Snap Diagnostics is a Medicare-registered Independent Diagnostic Testing Facility (IDTF) accredited by The Joint Commission. Snap provides a complete home sleep testing service, shipping tests directly to patients, with every study scored by Snap’s sleep technicians and interpreted by its sleep specialists, available in all 50 states.

Snap Diagnostics 是一家在 Medicare 注册的独立诊断检测设施（IDTF），并获得联合委员会认证。Snap 提供完整的家庭睡眠测试服务，直接将测试设备寄送给患者，所有研究均由 Snap 的睡眠技师进行评分，并由其睡眠专家进行解读，服务覆盖美国全部 50 个州。

Snap is a subsidiary of Beacon Biosignals. Learn more at snapdiagnostics.com..

Snap 是 Beacon Biosignals 的子公司。更多信息请访问 snapdiagnostics.com。

Media Contact

媒体联系人

Isabella Lazzareschi, Director of Marketing, Beacon Biosignals

伊莎贝拉·拉扎雷斯基，Beacon Biosignals 市场总监

isabella.lazzareschi@beacon.bio

isabella.lazzareschi@beacon.bio